{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T11:53:40Z","timestamp":1787313220817,"version":"build-2736575974"},"reference-count":82,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T00:00:00Z","timestamp":1731110400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neuropharmacology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/j.neuropharm.2024.110214","type":"journal-article","created":{"date-parts":[[2024,11,9]],"date-time":"2024-11-09T05:02:25Z","timestamp":1731128545000},"page":"110214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"special_numbering":"C","title":["MRS3997, a dual adenosine A2A\/A2B receptor agonist, reduces brain ischemic damage and alleviates neuroinflammation in rats"],"prefix":"10.1016","volume":"262","author":[{"given":"Ilaria","family":"Dettori","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Bulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2736-9150","authenticated-orcid":false,"given":"Giada","family":"Magni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cherchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1199-8019","authenticated-orcid":false,"given":"Francesca","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hobin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicita","family":"Pedata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8104-1493","authenticated-orcid":false,"given":"Kenneth A.","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Coppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.neuropharm.2024.110214_bib1","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1021\/jm061278q","article-title":"Structure-activity relationships of 2,N(6),5\u2019-substituted adenosine derivatives with potent activity at the A2B adenosine receptor","volume":"50","author":"Adachi","year":"2007","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.110214_bib2","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1161\/01.STR.27.10.1739","article-title":"Dynamics of polymorphonuclear leukocyte accumulation in acute cerebral infarction and their correlation with brain tissue damage","volume":"27","author":"Akopov","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110214_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.pneurobio.2005.06.004","article-title":"Microglia and inflammation-mediated neurodegeneration: multiple triggers with a common mechanism","volume":"76","author":"Block","year":"2005","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/nrn2038","article-title":"Microglia-mediated neurotoxicity: uncovering the molecular mechanisms","author":"Block","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110214_bib5","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1124\/pr.113.008029","article-title":"Purinergic signaling and blood vessels in health and disease","volume":"66","author":"Burnstock","year":"2014","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110214_bib6","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1179\/1743132815Y.0000000033","article-title":"Weight loss: indication of brain damage and effect of combined normobaric oxygen and ethanol therapy after stroke","volume":"37","author":"Cai","year":"2015","journal-title":"Neurol. Res."},{"key":"10.1016\/j.neuropharm.2024.110214_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0045250","article-title":"The neuron-astrocyte-microglia triad in normal brain ageing and in a model of neuroinflammation in the rat hippocampus","volume":"7","author":"Cerbai","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110214_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/glia.24593","article-title":"Adenosine A2B receptors differently modulate oligodendrogliogenesis and myelination depending on their cellular localization","author":"Cherchi","year":"2024","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2024.110214_bib9","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1161\/hs1101.098367","article-title":"Intravenous administration of human umbilical cord blood reduces behavioral deficits after stroke in rats","volume":"32","author":"Chen","year":"2001","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110214_bib12","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1111\/jnc.13724","article-title":"How does adenosine control neuronal dysfunction and neurodegeneration?","volume":"139","author":"Cuhna","year":"2016","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110214_bib13","first-page":"47","article-title":"[The cytoarchitecture of the rat globus pallidus]","volume":"22","author":"Danner","year":"1981","journal-title":"J. Hirnforsch."},{"key":"10.1016\/j.neuropharm.2024.110214_bib14","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.physbeh.2007.05.031","article-title":"Modulation of glial cell functions by adenosine receptors","volume":"92","author":"Dar\u00e9","year":"2007","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.neuropharm.2024.110214_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fphar.2020.588757","article-title":"Protective effect of adenosine A2B receptor agonist, BAY60-6583, against transient focal brain ischemia in rat","volume":"11","author":"Dettori","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0054722","article-title":"Oxidative stress and proinflammatory cytokines contribute to demyelination and axonal damage in a cerebellar culture model of neuroinflammation","volume":"8","author":"di Penta","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110214_bib17","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S0166-2236(99)01401-0","article-title":"Pathobiology of ischaemic stroke: an integrated view","volume":"22","author":"Dirnagl","year":"1999","journal-title":"Trends Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110214_bib18","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1113\/jphysiol.1929.sp002608","article-title":"The physiological activity of adenine compounds with especial reference to their action upon the mammalian heart1","volume":"68","author":"Drury","year":"1929","journal-title":"J. Physiol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib19","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.bmc.2005.09.011","article-title":"The benefits of the multi-target approach in drug design and discovery","volume":"14","author":"Espinoza-Fonseca","year":"2006","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.neuropharm.2024.110214_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuint.2023.105607","article-title":"Tetramethylpyrazine promotes axonal remodeling and modulates microglial polarization via JAK2-STAT1\/3 and GSK3-NF\u03baB pathways in ischemic stroke","volume":"170","author":"Feng","year":"2023","journal-title":"Neurochem. Int."},{"key":"10.1016\/j.neuropharm.2024.110214_bib21","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1161\/01.HYP.0000144800.21037.a5","article-title":"Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype","volume":"44","author":"Feoktistov","year":"2004","journal-title":"Hypertens. (Dallas, Tex. 1979)"},{"key":"10.1016\/j.neuropharm.2024.110214_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0015973","article-title":"Microglial morphology and dynamic behavior is regulated by ionotropic glutamatergic and GABAergic neurotransmission","volume":"6","author":"Fontainhas","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110214_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1124\/pr.110.003285","article-title":"International union of basic and clinical pharmacology. LXXXI. Nomenclature and classification of adenosine receptors--an update","volume":"63","author":"Fredholm","year":"2011","journal-title":"Pharmacol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110214_bib24","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1152\/physrev.00011.2017","article-title":"NEURONAL CELL DEATH. Neuronal cell death","volume":"98","author":"Fricker","year":"2018","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110214_bib25","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.brainresbull.2019.05.018","article-title":"Functional characterization of a novel adenosine A2B receptor agonist on short-term plasticity and synaptic inhibition during oxygen and glucose deprivation in the rat CA1 hippocampus","volume":"151","author":"Fusco","year":"2019","journal-title":"Brain Res. Bull."},{"key":"10.1016\/j.neuropharm.2024.110214_bib26","doi-asserted-by":"crossref","first-page":"399","DOI":"10.3389\/fphar.2018.00399","article-title":"The selective antagonism of adenosine A2B receptors reduces the synaptic failure and neuronal death induced by oxygen and glucose deprivation in rat CA1 Hippocampus in vitro","volume":"9","author":"Fusco","year":"2018","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib27","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.bcp.2014.05.008","article-title":"Probing biased\/partial agonism at the G protein-coupled A2B adenosine receptor","volume":"90","author":"Gao","year":"2014","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib28","volume":"vol. 2024","author":"Gao","year":"2024"},{"key":"10.1016\/j.neuropharm.2024.110214_bib29","first-page":"623","article-title":"Progression from ischemic injury to infarct following middle cerebral artery occlusion in the rat","volume":"142","author":"Garcia","year":"1993","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib31","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1161\/STROKEAHA.108.534503","article-title":"Temporal and spatial dynamics of cerebral immune cell accumulation in stroke","volume":"40","author":"Gelderblom","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110214_bib32","series-title":"Methods in Enzymology","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S0076-6879(02)45035-5","article-title":"Double-label confocal microscopy of phosphorylated protein kinases involved in long-term potentiation","author":"Giovannini","year":"2002"},{"key":"10.1016\/j.neuropharm.2024.110214_bib33","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1111\/ejn.12851","article-title":"Adenosine A2b receptors control A1 receptor-mediated inhibition of synaptic transmission in the mouse hippocampus","volume":"41","author":"Gon\u00e7alves","year":"2015","journal-title":"Eur. J. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110214_bib34","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.brainres.2009.08.050","article-title":"Adenosine A2A receptor deficiency reduces striatal glutamate outflow and attenuates brain injury induced by transient focal cerebral ischemia in mice","volume":"1297","author":"Gui","year":"2009","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110214_bib35","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1046\/j.1471-4159.2003.01919.x","article-title":"Evidence for functional adenosine A3 receptors in microglia cells","volume":"86","author":"Hammarberg","year":"2003","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110214_bib39","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.surneu.2005.12.028","article-title":"Inflammation in stroke and focal cerebral ischemia","volume":"66","author":"Huang","year":"2006","journal-title":"Surg. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib40","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7150\/ijms.8140","article-title":"Glial scar formation occurs in the human brain after ischemic stroke","volume":"11","author":"Huang","year":"2014","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.neuropharm.2024.110214_bib42","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/jcbfm.2015.45","article-title":"Targeting neutrophils in ischemic stroke: translational insights from experimental studies","volume":"35","author":"Jickling","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib43","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1161\/STROKEAHA.107.497602","article-title":"Weight loss after stroke","volume":"39","author":"J\u00f6onsson","year":"2008","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110214_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.expneurol.2020.113508","article-title":"CNS and peripheral immunity in cerebral ischemia: partition and interaction","volume":"335","author":"Kim","year":"2021","journal-title":"Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib45","doi-asserted-by":"crossref","first-page":"e6784","DOI":"10.1371\/journal.pone.0006784","article-title":"Selective deletion of the A1 adenosine receptor abolishes heart-rate slowing effects of intravascular adenosine in vivo","volume":"4","author":"Koeppen","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/j.neuropharm.2024.110214_bib46","doi-asserted-by":"crossref","DOI":"10.1097\/00005072-196410000-00012","article-title":"The rat brain. A stereotaxic atlas","author":"K\u00f6nig","year":"1964","journal-title":"J. Neuropathol. Exp. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib47","series-title":"The Rat Atlas: A Stereotaxic Atlas of the Forebrain and Lower Parts of the Brain Stem","author":"K\u00f6nig","year":"1967"},{"key":"10.1016\/j.neuropharm.2024.110214_bib48","doi-asserted-by":"crossref","first-page":"445","DOI":"10.4049\/jimmunol.1101224","article-title":"Adenosine augments IL-10 production by microglial cells through an A2B adenosine receptor-mediated process","volume":"188","author":"Koscs\u00f3","year":"2012","journal-title":"J. Immunol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib49","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1615\/CritRevNeurobiol.v18.i1-2.150","article-title":"Inflammation in ischemic brain injury: timing is important","volume":"18","author":"Kriz","year":"2006","journal-title":"Crit. Rev. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/BF00688633","article-title":"The biphasic opening of the blood-brain barrier to proteins following temporary middle cerebral artery occlusion","volume":"68","author":"Kuroiwa","year":"1985","journal-title":"Acta Neuropathol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2023.115184","article-title":"Drugs targeting adenosine signaling pathways: a current view","volume":"165","author":"Kutryb-Zaj\u0105c","year":"2023","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.neuropharm.2024.110214_bib52","doi-asserted-by":"crossref","DOI":"10.3389\/fnagi.2014.00322","article-title":"The neuron-astrocyte-microglia triad in a rat model of chronic cerebral hypoperfusion: protective effect of dipyridamole","volume":"6","author":"Lana","year":"2014","journal-title":"Front. Aging Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110214_bib53","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1046\/j.1471-4159.2001.00607.x","article-title":"Adenosine in the central nervous system: release mechanisms and extracellular concentrations","volume":"79","author":"Latini","year":"2001","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110214_bib54","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.nbd.2017.08.011","article-title":"Inhibition of tPA-induced hemorrhagic transformation involves adenosine A2b receptor activation after cerebral ischemia","volume":"108","author":"Li","year":"2017","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110214_bib56","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1152\/physrev.1999.79.4.1431","article-title":"Ischemic cell death in brain neurons","volume":"79","author":"Lipton","year":"1999","journal-title":"Physiol. Rev."},{"key":"10.1016\/j.neuropharm.2024.110214_bib58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/2396987319883160","article-title":"Economic burden of stroke across Europe: a population-based cost analysis","volume":"5","author":"Luengo-Fernandez","year":"2020","journal-title":"Eur. Stroke J."},{"key":"10.1016\/j.neuropharm.2024.110214_bib59","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.neuropharm.2012.12.002","article-title":"Effects of oxygen and glucose deprivation on synaptic transmission in rat dentate gyrus: role of A2A adenosine receptors","volume":"67","author":"Maraula","year":"2013","journal-title":"Neuropharmacology"},{"key":"10.1016\/j.neuropharm.2024.110214_bib60","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.brainres.2014.01.014","article-title":"Low doses of the selective adenosine A2A receptor agonist CGS21680 are protective in a rat model of transient cerebral ischemia","volume":"1551","author":"Melani","year":"2014","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110214_bib61","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.brainres.2005.12.010","article-title":"The selective A2A receptor antagonist SCH 58261 protects from neurological deficit, brain damage and activation of p38 MAPK in rat focal cerebral ischemia","volume":"1073\u20131074","author":"Melani","year":"2006","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.neuropharm.2024.110214_bib94","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/S0006-8993(02)03753-8","article-title":"The selective A2A receptor antagonist SCH 58261 reduces striatal transmitter outflow, turning behavior and ischemic brain damage induced by permanent focal ischemia in the rat","volume":"959","author":"Melani","year":"2003","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110214_bib62","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1161\/01.STR.30.11.2448","article-title":"Striatal outflow of adenosine, excitatory amino acids, gamma-aminobutyric acid, and taurine in awake freely moving rats after middle cerebral artery occlusion: correlations with neurological deficit and histopathological damage","volume":"30","author":"Melani","year":"1999","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110214_bib64","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/glia.22861","article-title":"A2a and a2b adenosine receptors affect HIF-1\u03b1 signaling in activated primary microglial cells","volume":"63","author":"Merighi","year":"2015","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2024.110214_bib65","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1100\/tsw.2011.22","article-title":"Anti-inflammatory and immunosuppressive effects of the A2A adenosine receptor","volume":"11","author":"Milne","year":"2011","journal-title":"Sci. World J."},{"key":"10.1016\/j.neuropharm.2024.110214_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1742-2094-10-4","article-title":"A quantitative spatiotemporal analysis of microglia morphology during ischemic stroke and reperfusion","volume":"10","author":"Morrison","year":"2013","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2024.110214_bib67","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.coph.2009.05.005","article-title":"The adenosinergic immunomodulatory drugs","volume":"9","author":"Ohta","year":"2009","journal-title":"Curr. Opin. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib68","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/nn.2341","article-title":"Adenosine A(2A) receptor mediates microglial process retraction","volume":"12","author":"Orr","year":"2009","journal-title":"Nat. Neurosci."},{"key":"10.1016\/j.neuropharm.2024.110214_bib69","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1161\/01.STR.27.9.1641","article-title":"Cerebral white matter is highly vulnerable to ischemia","volume":"27","author":"Pantoni","year":"1996","journal-title":"Stroke"},{"key":"10.1016\/j.neuropharm.2024.110214_bib70","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.neuropharm.2015.11.007","article-title":"Purinergic signalling in brain ischemia","volume":"104","author":"Pedata","year":"2016","journal-title":"Neuropharmacology"},{"issue":"5","key":"10.1016\/j.neuropharm.2024.110214_bib95","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1476-5381.2009.00218.x","article-title":"The adenosine A2A receptor antagonist ZM241385 enhances neuronal survival after oxygen-glucose deprivation in rat CA1 hippocampal slices","volume":"157","author":"Pugliese","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib71","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s40169-017-0181-2","article-title":"A perspective on multi-target drug discovery and design for complex diseases","volume":"7","author":"Ramsay","year":"2018","journal-title":"Clin. Transl. Med."},{"key":"10.1016\/j.neuropharm.2024.110214_bib73","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.brainres.2006.10.057","article-title":"The effect of activated microglia on astrogliosis parameters in astrocyte cultures","volume":"1129","author":"R\u00f6hl","year":"2007","journal-title":"Brain Res."},{"key":"10.1016\/j.neuropharm.2024.110214_bib74","doi-asserted-by":"crossref","DOI":"10.3791\/4038-v","article-title":"Mouse model of intraluminal MCAO: cerebral infarct evaluation by cresyl violet staining","author":"Rousselet","year":"2012","journal-title":"J. Vis. Exp."},{"key":"10.1016\/j.neuropharm.2024.110214_bib75","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.nbd.2008.08.005","article-title":"Blood-brain barrier tight junction permeability and ischemic stroke","volume":"32","author":"Sandoval","year":"2008","journal-title":"Neurobiol. Dis."},{"key":"10.1016\/j.neuropharm.2024.110214_bib76","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/01.WCB.0000061881.75234.5E","article-title":"Macrophages and microglia in central nervous system injury: are they helpful or harmful?","volume":"23","author":"Schwartz","year":"2003","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib77","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1476-5381.2009.00157.x","article-title":"Triggering neurotrophic factor actions through adenosine A2A receptor activation: implications for neuroprotection","volume":"158","author":"Sebasti\u00e3o","year":"2009","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib78","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/j.mam.2016.11.002","article-title":"Insulin\/adenosine axis linked signalling","volume":"55","author":"Silva","year":"2017","journal-title":"Mol. Aspect. Med."},{"key":"10.1016\/j.neuropharm.2024.110214_bib79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12974-021-02360-3","article-title":"Citrullinated myelin induces microglial TNF\u03b1 and inhibits endogenous repair in the cuprizone model of demyelination","volume":"18","author":"Standiford","year":"2021","journal-title":"J. Neuroinflammation"},{"key":"10.1016\/j.neuropharm.2024.110214_bib80","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1002\/1098-1136(200103)33:3<256::AID-GLIA1024>3.0.CO;2-J","article-title":"Dynamics of microglial activation: a confocal time-lapse analysis in hippocampal slices","volume":"33","author":"Stence","year":"2001","journal-title":"Glia"},{"key":"10.1016\/j.neuropharm.2024.110214_bib81","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S0301-0082(98)00034-3","article-title":"Inflammation and glial responses in ischemic brain lesions","volume":"56","author":"Stoll","year":"1998","journal-title":"Prog. Neurobiol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib82","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1038\/jcbfm.2015.174","article-title":"A novel SPECT-based approach reveals early mechanisms of central and peripheral inflammation after cerebral ischemia","volume":"35","author":"Szigeti","year":"2015","journal-title":"J. Cerebr. Blood Flow Metabol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib84","article-title":"Regulation of A 2A adenosine receptor expression and functioning following permanent focal ischemia in rat brain","volume":"0","author":"Trincavelli","year":"2007","journal-title":"J. Neurochem."},{"key":"10.1016\/j.neuropharm.2024.110214_bib85","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1002\/ana.410150608","article-title":"Focal cerebral ischemia in the rat: topography of hemodynamic and histopathological changes","volume":"15","author":"Tyson","year":"1984","journal-title":"Ann. Neurol."},{"key":"10.1016\/j.neuropharm.2024.110214_bib86","doi-asserted-by":"crossref","DOI":"10.1007\/s11064-005-8792-1","article-title":"The role of glial adenosine receptors in neural resilience and the neurobiology of mood disorders","author":"Van Calker","year":"2005","journal-title":"Neurochem. Res."},{"key":"10.1016\/j.neuropharm.2024.110214_bib87","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1124\/jpet.111.181792","article-title":"A role for the low-affinity A2B adenosine receptor in regulating superoxide generation by murine neutrophils","volume":"338","author":"Van Der Hoeven","year":"2011","journal-title":"J. Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.neuropharm.2024.110214_bib96","series-title":"World Health Organization: Global Health Estimates: Life expectancy and leading causes of death and disability, 2000-2019","year":"2020"},{"key":"10.1016\/j.neuropharm.2024.110214_bib88","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1097\/WNR.0000000000001553","article-title":"Systematic evaluation during early-phase ischemia predicts outcomes in middle cerebral artery occlusion mice","volume":"32","author":"Xiao","year":"2021","journal-title":"Neuroreport"},{"key":"10.1016\/j.neuropharm.2024.110214_bib89","doi-asserted-by":"crossref","DOI":"10.3389\/fchem.2020.00142","article-title":"LigBuilder V3: A Multi-Target de novo Drug Design Approach","volume":"8","author":"Yuan","year":"2020","journal-title":"Front. Chem."},{"key":"10.1016\/j.neuropharm.2024.110214_bib90","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0022-510X(94)90234-8","article-title":"Temporal profile of ischemic tissue damage, neutrophil response, and vascular plugging following permanent and transient (2H) middle cerebral artery occlusion in the rat","volume":"125","author":"Zhang","year":"1994","journal-title":"J. Neurol. Sci."},{"key":"10.1016\/j.neuropharm.2024.110214_bib91","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.brainresbull.2018.11.003","article-title":"Neuroprotective effects of matrix metalloproteinases in cerebral ischemic rats by promoting activation and migration of astrocytes and microglia","volume":"146","author":"Zhang","year":"2019","journal-title":"Brain Res. Bull."}],"container-title":["Neuropharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0028390824003836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T17:14:43Z","timestamp":1738430083000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0028390824003836"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1]]},"references-count":82,"alternative-id":["S0028390824003836"],"URL":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110214","relation":{},"ISSN":["0028-3908"],"issn-type":[{"value":"0028-3908","type":"print"}],"subject":[],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"MRS3997, a dual adenosine A2A\/A2B receptor agonist, reduces brain ischemic damage and alleviates neuroinflammation in rats","name":"articletitle","label":"Article Title"},{"value":"Neuropharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.neuropharm.2024.110214","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"110214"}}